Diabetes Experts Partner With Novo Nordisk to Provide New Patient...(areas such as hemostasis management grow...),Health

Date:5/14/2009

areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. With headquarters in Denmark, Novo Nordisk employs more than 27,000 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For global information, visit novonordisk.com; for United States information, visit novonordisk-us.com.

'/>"/>

SOURCE American Association of Clinical Endocrinologists Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine news :

1. Nordstrom Beat the Bridge to Beat Diabetes Run to Temporarily Suspend Traffic in University District on Sunday, May 17
2. FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
3. Productivity Takes a Hit From Obesity, Diabetes
4. Indianapolis Residents View Economic Challenges as Significant Barrier to Properly Managing Type 2 Diabetes
5. President of IDF calls for government focus and spending on diabetes and other NCDs
6. Groundbreaking Diabetes Disease Management Program Honored With URAC National Best Practices Award
7. Blue Cross and Blue Shield Funds Diabetes Education at Saints Mary and Elizabeth Medical Center
8. City Leaders Launch Medicare Diabetes Screening Project in Augusta
9. Photo: Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels of Patients with Type 2 Diabetes in TITRATE(R) Study
10. Undiagnosed diabetes takes economic toll
11. Diabetes Discharge Planning is this the latest Topic in Focus at the Diabetes Best Practices Website